In this issue of Urologic Clinics of North America, guest editor Dr. Kevin R. Loughlin brings his considerable expertise to the topic of Testosterone. With about 2 out of 10 men older than 60 years having low testosterone (American Urological Association), coupled with an aging population, this issue is an important resource for all urologists for effectively treating men and improving outcomes. It provides a current update on testosterone in men from top experts in the field, covering prostate cancer treatment, the use of anabolic steroids, hypogonadism, testosterone replacement, and more.
The Inexorable March of Prostate Cancer Research: Testosterone and Beyond Testosterone Therapy and Prostate Cancer: Incorporating Low-Level Evidence into Practical Recommendations Current Management and Controversies Surrounding Andropause Benefits and Risks of Testosterone Treatment of Older Men with Hypogonadism Testosterone and the Androgen Receptor Molecular Mechanisms of Castrate-Resistant Prostate Cancer Testosterone and Male Sexual Function What We Have Learned from The Testosterone Trials Androgenic Steroids Use and Abuse: Past, Present, and Future Testosterone Assays Testosterone Replacement Options The Prostate as an Endocrine Organ: Its Modulation of Serum Testosterone
Komentarze (0)
Chwilowo nie możesz polubić tej opinii
Zgłoś komentarz
Czy jesteś pewien, że chcesz zgłosić ten komentarz?
Zgłoszenie wysłane
Twój komentarz został wysłany i będzie widoczny po zatwierdzeniu przez moderatora.